Teva loses key ruling in NJ court as Federal Circuit prepares for hearing over Orange Book delisting order
An attempt by Teva Pharmaceuticals to have a New Jersey federal judge modify the claim construction of five patents at the center of a patent infringement case before the US Court...To view the full article, register now.
Already a subscriber? Click here to view full article